Combo Bio-engineered Sirolimus Eluting Stent: Phase II started

OrbusNeich began the open-label, international Phase II REMEDEE trial in 180 patients to compare its Combo Bio-engineered stent vs. Taxus Liberte paclitaxel-eluting stent from Boston Scientific Corp...